Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D DiMarchi

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Molecular Metabolism|March 17, 2021
Advances in the treatment of metabolic diseasesRichard D DiMarchi
Molecular Metabolism|October 25, 2018
"Let's Stay Together"; GIP and GLP-1 dual agonism in the treatment of metabolic diseaseRichard D DiMarchi
Biopolymers|July 2, 2010
Synthesis and characterization of ester-based prodrugs of glucagon-like peptide 1Arnab De, Richard D DiMarchi
Journal of Medicinal Chemistry|June 16, 2021
Icodec Advances the Prospect of Once-Weekly Insulin InjectionRichard D DiMarchi, John P Mayer
Diabetes|July 22, 2020
Smarter Modeling to Enable a Smarter InsulinSimeon I Taylor, Richard D DiMarchi
Diabetes|May 24, 2012
Outstanding Scientific Achievement Award Lecture 2011: defeating diabesity: the case for personalized combinatorial therapiesMatthias H Tschöp, Richard D DiMarchi
Chemistry & Biology|August 30, 2005
Drugging the undruggableJohn P Mayer, Richard D Dimarchi
Biopolymers|April 6, 2007
Insulin structure and functionJohn P Mayer, Faming Zhang, Richard D DiMarchi
Cell Metabolism|August 3, 2017
Once Blind, Now We See GLP-1 Molecular ActionJohn P Mayer, Matthias H Tschöp, Richard D DiMarchi
Future Medicinal Chemistry|March 18, 2020
Recent advances in the chemical synthesis of insulin and related peptidesFlorence M Brunel, John P Mayer, Richard D DiMarchi
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Molecular Metabolism|March 17, 2021
Advances in the treatment of metabolic diseasesRichard D DiMarchi
Molecular Metabolism|October 25, 2018
"Let's Stay Together"; GIP and GLP-1 dual agonism in the treatment of metabolic diseaseRichard D DiMarchi
Biopolymers|July 2, 2010
Synthesis and characterization of ester-based prodrugs of glucagon-like peptide 1Arnab De, Richard D DiMarchi
Journal of Medicinal Chemistry|June 16, 2021
Icodec Advances the Prospect of Once-Weekly Insulin InjectionRichard D DiMarchi, John P Mayer
Diabetes|July 22, 2020
Smarter Modeling to Enable a Smarter InsulinSimeon I Taylor, Richard D DiMarchi
Diabetes|May 24, 2012
Outstanding Scientific Achievement Award Lecture 2011: defeating diabesity: the case for personalized combinatorial therapiesMatthias H Tschöp, Richard D DiMarchi
Chemistry & Biology|August 30, 2005
Drugging the undruggableJohn P Mayer, Richard D Dimarchi
Biopolymers|April 6, 2007
Insulin structure and functionJohn P Mayer, Faming Zhang, Richard D DiMarchi
Cell Metabolism|August 3, 2017
Once Blind, Now We See GLP-1 Molecular ActionJohn P Mayer, Matthias H Tschöp, Richard D DiMarchi
Future Medicinal Chemistry|March 18, 2020
Recent advances in the chemical synthesis of insulin and related peptidesFlorence M Brunel, John P Mayer, Richard D DiMarchi
Pageof 13